Selected research
Industry Research
Digital Insomnia Therapeutics Industry Research Report 2026
Market perspective
The global Digital Insomnia Therapeutics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Digital Insomnia Therapeutics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Digital Insomnia Therapeutics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Digital Insomnia Therapeutics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Digital Insomnia Therapeutics include Headspace Inc, Big Health, Calm, Nox Health, Pear Therapeutics, OPTT Inc, SilverCloud, Curv Health and Bodymatter Inc and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Digital Insomnia Therapeutics market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Digital Insomnia Therapeutics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Digital Insomnia Therapeutics Market by Company
Headspace Inc
Big Health
Calm
Nox Health
Pear Therapeutics
OPTT Inc
SilverCloud
Curv Health
Bodymatter Inc
PrimeNap
Digital Insomnia Therapeutics Segment by Type
Sleep Tracking App
Relaxation and Meditation Apps
CBT-I
Others
Digital Insomnia Therapeutics Segment by Application
Medical
Household
Digital Insomnia Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Insomnia Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Insomnia Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Insomnia Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Digital Insomnia Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sleep Tracking App
- Relaxation and Meditation Apps
- CBT-I
- Others
Applications
- Medical
- Household
Companies covered
- Headspace Inc
- Big Health
- Calm
- Nox Health
- Pear Therapeutics
- OPTT Inc
- SilverCloud
- Curv Health
- Bodymatter Inc
- PrimeNap
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Digital Insomnia Therapeutics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Sleep Tracking App
- 2.2.3 Relaxation and Meditation Apps
- 2.2.4 CBT-I
- 2.2.5 Others
- 2.3 Digital Insomnia Therapeutics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical
- 2.3.3 Household
- 2.4 Assumptions and Limitations
3 Digital Insomnia Therapeutics Breakdown Data by Type
- 3.1 Global Digital Insomnia Therapeutics Historic Market Size by Type (2021-2026)
- 3.2 Global Digital Insomnia Therapeutics Forecasted Market Size by Type (2027-2032)
4 Digital Insomnia Therapeutics Breakdown Data by Application
- 4.1 Global Digital Insomnia Therapeutics Historic Market Size by Application (2021-2026)
- 4.2 Global Digital Insomnia Therapeutics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Digital Insomnia Therapeutics Market Perspective (2021-2032)
- 5.2 Global Digital Insomnia Therapeutics Growth Trends by Region
- 5.2.1 Global Digital Insomnia Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Digital Insomnia Therapeutics Historic Market Size by Region (2021-2026)
- 5.2.3 Digital Insomnia Therapeutics Forecasted Market Size by Region (2027-2032)
- 5.3 Digital Insomnia Therapeutics Market Dynamics
- 5.3.1 Digital Insomnia Therapeutics Industry Trends
- 5.3.2 Digital Insomnia Therapeutics Market Drivers
- 5.3.3 Digital Insomnia Therapeutics Market Challenges
- 5.3.4 Digital Insomnia Therapeutics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Digital Insomnia Therapeutics Players by Revenue
- 6.1.1 Global Top Digital Insomnia Therapeutics Players by Revenue (2021-2026)
- 6.1.2 Global Digital Insomnia Therapeutics Revenue Market Share by Players (2021-2026)
- 6.2 Global Digital Insomnia Therapeutics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Digital Insomnia Therapeutics Head Office and Area Served
- 6.4 Global Digital Insomnia Therapeutics Players, Product Type & Application
- 6.5 Global Digital Insomnia Therapeutics Manufacturers Established Date
- 6.6 Global Digital Insomnia Therapeutics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Digital Insomnia Therapeutics Market Size (2021-2032)
- 7.2 North America Digital Insomnia Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Digital Insomnia Therapeutics Market Size by Country (2021-2026)
- 7.4 North America Digital Insomnia Therapeutics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Digital Insomnia Therapeutics Market Size (2021-2032)
- 8.2 Europe Digital Insomnia Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Digital Insomnia Therapeutics Market Size by Country (2021-2026)
- 8.4 Europe Digital Insomnia Therapeutics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Insomnia Therapeutics Market Size (2021-2032)
- 9.2 Asia-Pacific Digital Insomnia Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Digital Insomnia Therapeutics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Digital Insomnia Therapeutics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Digital Insomnia Therapeutics Market Size (2021-2032)
- 10.2 South America Digital Insomnia Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Digital Insomnia Therapeutics Market Size by Country (2021-2026)
- 10.4 South America Digital Insomnia Therapeutics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Insomnia Therapeutics Market Size (2021-2032)
- 11.2 Middle East & Africa Digital Insomnia Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Digital Insomnia Therapeutics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Digital Insomnia Therapeutics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Headspace Inc
- 12.1.1 Headspace Inc Company Information
- 12.1.2 Headspace Inc Business Overview
- 12.1.3 Headspace Inc Revenue in Digital Insomnia Therapeutics Business (2021-2026)
- 12.1.4 Headspace Inc Digital Insomnia Therapeutics Product Portfolio
- 12.1.5 Headspace Inc Recent Developments
- 12.2 Big Health
- 12.2.1 Big Health Company Information
- 12.2.2 Big Health Business Overview
- 12.2.3 Big Health Revenue in Digital Insomnia Therapeutics Business (2021-2026)
- 12.2.4 Big Health Digital Insomnia Therapeutics Product Portfolio
- 12.2.5 Big Health Recent Developments
- 12.3 Calm
- 12.3.1 Calm Company Information
- 12.3.2 Calm Business Overview
- 12.3.3 Calm Revenue in Digital Insomnia Therapeutics Business (2021-2026)
- 12.3.4 Calm Digital Insomnia Therapeutics Product Portfolio
- 12.3.5 Calm Recent Developments
- 12.4 Nox Health
- 12.4.1 Nox Health Company Information
- 12.4.2 Nox Health Business Overview
- 12.4.3 Nox Health Revenue in Digital Insomnia Therapeutics Business (2021-2026)
- 12.4.4 Nox Health Digital Insomnia Therapeutics Product Portfolio
- 12.4.5 Nox Health Recent Developments
- 12.5 Pear Therapeutics
- 12.5.1 Pear Therapeutics Company Information
- 12.5.2 Pear Therapeutics Business Overview
- 12.5.3 Pear Therapeutics Revenue in Digital Insomnia Therapeutics Business (2021-2026)
- 12.5.4 Pear Therapeutics Digital Insomnia Therapeutics Product Portfolio
- 12.5.5 Pear Therapeutics Recent Developments
- 12.6 OPTT Inc
- 12.6.1 OPTT Inc Company Information
- 12.6.2 OPTT Inc Business Overview
- 12.6.3 OPTT Inc Revenue in Digital Insomnia Therapeutics Business (2021-2026)
- 12.6.4 OPTT Inc Digital Insomnia Therapeutics Product Portfolio
- 12.6.5 OPTT Inc Recent Developments
- 12.7 SilverCloud
- 12.7.1 SilverCloud Company Information
- 12.7.2 SilverCloud Business Overview
- 12.7.3 SilverCloud Revenue in Digital Insomnia Therapeutics Business (2021-2026)
- 12.7.4 SilverCloud Digital Insomnia Therapeutics Product Portfolio
- 12.7.5 SilverCloud Recent Developments
- 12.8 Curv Health
- 12.8.1 Curv Health Company Information
- 12.8.2 Curv Health Business Overview
- 12.8.3 Curv Health Revenue in Digital Insomnia Therapeutics Business (2021-2026)
- 12.8.4 Curv Health Digital Insomnia Therapeutics Product Portfolio
- 12.8.5 Curv Health Recent Developments
- 12.9 Bodymatter Inc
- 12.9.1 Bodymatter Inc Company Information
- 12.9.2 Bodymatter Inc Business Overview
- 12.9.3 Bodymatter Inc Revenue in Digital Insomnia Therapeutics Business (2021-2026)
- 12.9.4 Bodymatter Inc Digital Insomnia Therapeutics Product Portfolio
- 12.9.5 Bodymatter Inc Recent Developments
- 12.10 PrimeNap
- 12.10.1 PrimeNap Company Information
- 12.10.2 PrimeNap Business Overview
- 12.10.3 PrimeNap Revenue in Digital Insomnia Therapeutics Business (2021-2026)
- 12.10.4 PrimeNap Digital Insomnia Therapeutics Product Portfolio
- 12.10.5 PrimeNap Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst